Skip to main content
JOHNSON & JOHNSON logo

JOHNSON & JOHNSON — Investor Relations & Filings

Ticker · JNJ ISIN · US4781601046 LEI · 549300G0CFPGEF6X2043 US Manufacturing
Open in API
Filings indexed 3,142 across all filing types
Latest filing 2022-04-25 Director's Dealing
Country US United States of America
Listing US JNJ

About JOHNSON & JOHNSON

https://www.jnj.com/

Johnson & Johnson is a healthcare company that operates through two primary segments: Innovative Medicine and MedTech. The Innovative Medicine division is focused on the research, development, and delivery of new treatments for complex diseases in areas such as oncology, immunology, neuroscience, and cardiopulmonary conditions. The MedTech segment develops and provides a broad portfolio of medical technologies and solutions. It innovates in fields including surgery, orthopaedics, vision, and interventional solutions, aiming to create smarter, less invasive, and more personalized healthcare treatments. The company's mission is to address significant health challenges through science-based innovation at the intersection of biology and technology.

Recent filings

Filing Released Lang Actions
Director's Dealing 2022
Director's Dealing
2022-04-25 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated April 19, 2022, by Johnson & Johnson. It announces the company's sales and earnings for the first quarter ended April 3, 2022, and includes a press release and unaudited supplementary sales data and condensed consolidated statement of earnings. The Form 8-K is a current report used to announce material events, including earnings releases. The document is relatively short (3332 characters) and primarily serves as an announcement of quarterly financial results rather than a full detailed report. Therefore, it fits the definition of an Earnings Release (ER), which is the initial announcement of quarterly/periodical financial results with key highlights only.
2022-04-19 English
Proxy Solicitation & Information Statement 2022
Proxy Solicitation & Information Statement Classification · 95% confidence The document is titled 'NOTICE OF EXEMPT SOLICITATION (VOLUNTARY SUBMISSION)' and is addressed to shareholders urging them to vote for a specific proposal at the upcoming Annual Stockholders Meeting. It discusses a shareholder proposal related to executive compensation adjustments concerning legal and compliance costs, specifically related to opioid litigation. The document references the company's annual report and proxy statement but does not itself contain financial statements or detailed financial data. It is a solicitation letter aimed at influencing shareholder voting on a proxy proposal, which aligns with materials sent to shareholders to provide information and request votes for meetings. Therefore, this document fits the category of Proxy Solicitation & Information Statement (PSI). The document length (8887 characters) and content support this classification rather than a full report or announcement of a report publication.
2022-03-31 English
Proxy Solicitation & Information Statement 2022
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Notice of Exempt Solicitation related to a shareholder proposal for the upcoming Annual General Meeting (AGM) of Johnson & Johnson. It urges shareholders to vote on a specific proposal concerning the company's lobbying activities and alignment with its position on universal health coverage. The document is not a report itself but rather a solicitation and advocacy material related to a shareholder vote at the AGM. It does not contain financial statements, audit information, or management discussion of results. It is also not a proxy statement or voting results announcement but a solicitation notice for a shareholder proposal. Therefore, the document best fits the category of Proxy Solicitation & Information Statement (PSI).
2022-03-31 English
Proxy Solicitation & Information Statement 2022
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Notice of Exempt Solicitation filed on PX14A6G form, which is used for proxy solicitation materials exempt from certain filing requirements under SEC rules. It is submitted by Oxfam America urging shareholders of Johnson & Johnson to vote FOR a specific shareholder proposal at the Annual Meeting. The content focuses on a shareholder proposal regarding transparency and reporting on COVID-19 vaccine pricing and access. The document is not a report itself but a solicitation communication related to a proxy vote. It does not contain financial statements, earnings data, or management discussion of results. It is not an announcement of voting results but a solicitation prior to the vote. Therefore, the filing type corresponds to Proxy Solicitation & Information Statement (PSI).
2022-03-28 English
Proxy Solicitation & Information Statement 2022
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a shareholder proposal submitted to Johnson & Johnson regarding a third-party racial justice audit. It is a detailed proposal urging shareholders to vote for a specific item on the company's proxy statement. The document discusses shareholder activism, corporate governance issues, and social responsibility topics, but it is not a financial report, earnings release, or regulatory filing. It is not an announcement of voting results or a proxy solicitation itself, but rather a proposal intended to be included in a proxy statement. The document is lengthy and substantive, focusing on governance and social issues rather than financial data or management changes. Therefore, the most appropriate classification is Proxy Solicitation & Information Statement (PSI), as it relates to materials sent to shareholders to provide information and request votes for meetings, specifically a shareholder proposal for the proxy.
2022-03-22 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.